Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. ViiV adds another innovative treatment to its growing HIV arsenal
  2. FDA expands Ibrance’s label to include male breast cancer patients
  3. Gilead submits sNDA to FDA to expand HIV label for Descovy
  4. NICE recommends BMS’ Opdivo-Yervoy combination for RCC
  5. ViiV announces long-term positive results for Juluca combination

Latest Content

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top